A year with the 988 Lifeline: What worked? What challenges lie ahead?
Mental health experts say the three-digit number has made help more accessible than before.
Watch CBS News
Mental health experts say the three-digit number has made help more accessible than before.
Fans have been working overtime in the Cains' apartment for over a month after they discovered their unit's air conditioning was not working. They say their property management company continued to overlook her request to fix the air conditioner.
Although mosquitoes with West Nile have been confirmed in several counties across the state, this is the first human case documented for 2023.
The City of Golden will vote on a ban on flavored nicotine products on Tuesday night.
Heat waves and fine particulate pollution combine to raise heart attack risk, according to a new study published in American Heart Association's journal Circulation.
Nearly all cases of infection by Naegleria fowleri are fatal. The amoeba enters the body through the nose and travels to the brain.
The report also found that White non-Hispanic Americans between 18 and 24 vape more than Latino, Asian or Black youth in the same age group.
Some providers of a special therapy for children suffering from autism in Colorado are warning of a pending care crisis because Medicaid reimbursement rates are not keeping up with inflation.
Only 5% of people with glioblastoma survive for five years or more. John Bienvenu is cancer-free six years after his diagnosis.
Why do some people not get COVID symptoms? Here's what scientists recently found out about the genetic advantage of "super dodgers."
A major Pfizer pharmaceutical plant was severely damaged after a deadly tornado ripped through North Carolina on Wednesday.
An annual ranking of the United States' fittest cities has been released, and Denver has landed in the Top 10.
Researchers found that, over three years, cognitive decline slowed by 48% in people with increased risk factors for dementia.
The annual raking of the United States' fittest cities is here, and it's good news for those who live near the nation's capital.
Eli Lilly's experimental Alzheimer's drug donanemab can modestly slow the worsening of the disease by about four to seven months, according to researchers.
